SSA
CRDF icon

Schonfeld Strategic Advisors’s Cardiff Oncology CRDF Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-133,887
Closed -$2.41M – 1842
2020
Q4 		$2.41M Sell
133,887
-37,640
-22% -$662K 0.03% 555
2020
Q3 		$2.43M Buy
171,527
+111,827
+187% +$738K 0.05% 453
2020
Q2 		$299K Buy
+59,700
New +$122K 0.01% 995
2016
Q2 		– Sell
-241
Closed -$81K – 454
2016
Q1 		$81K Buy
+241
New +$82K 0.03% 290

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Schonfeld Strategic Advisors's CRDF Position: Q1 2021 in Review

Schonfeld Strategic Advisors sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 133,887 shares — an estimated $2.41M sold.

Schonfeld Strategic Advisors first reported a position in CRDF in Q1 2016 and held it in 4 quarters. The position peaked at $2.43M in Q3 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

  • Schonfeld Strategic Advisors reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 133,887 Cardiff Oncology shares in Q1 2021, an estimated $2.41M.
  • Schonfeld Strategic Advisors first reported a position in Cardiff Oncology in Q1 2016 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Cardiff Oncology position peaked at $2.43M in Q3 2020.
  • 73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.